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Abstract
Background: Neutrophils are key-players in the innate host defense and their programmed cell death and removal are
essential for efficient resolution of inflammation. These cells recognize a variety of pathogens, and the NOD-like receptors
(NLRs) have been suggested as intracellular sensors of microbial components and cell injury/stress. Some NLR will upon
activation form multi-protein complexes termed inflammasomes that result in IL-1b production. NLR mutations are
associated with auto-inflammatory syndromes, and our previous data propose NLRP3 (Q705K)/CARD-8 (C10X)
polymorphisms to contribute to increased risk and severity of inflammatory disease by acting as genetic susceptibility
factors. These gene products are components of the NALP3 inflammasome, and approximately 6.5% of the Swedish
population are heterozygote carriers of these combined gene variants. Since patients carrying the Q705K/C10X
polymorphisms display leukocytosis, the aim of the present study was to find out whether the inflammatory phenotype was
related to dysfunctional apoptosis and impaired clearance of neutrophils by macrophages.
Methods and Findings: Patients carrying the Q705K/C10X polymorphisms displayed significantly delayed spontaneous as
well as microbe-induced apoptosis compared to matched controls. Western blotting revealed increased levels and
phosphorylation of Akt and Mcl-1 in the patients’ neutrophils. In contrast to macrophages from healthy controls,
macrophages from the patients produced lower amounts of TNF; suggesting impaired macrophage clearance response.
Conclusions: The Q705K/C10X polymorphisms are associated with delayed apoptosis of neutrophils. These findings are
explained by altered involvement of different regulators of apoptosis, resulting in an anti-apoptotic profile. Moreover, the
macrophage response to ingestion of microbe-induced apoptotic neutrophils is altered in the patients. Taken together, the
patients display impaired turnover and clearance of apoptotic neutrophils, pointing towards a dysregulated innate immune
response that influences the resolution of inflammation. The future challenge is to understand how microbes affect the
activation of inflammasomes, and why this interaction will develop into severe inflammatory disease in certain individuals.
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Introduction
Phagocytic cells, neutrophil granulocytes and macrophages, are
important mediator cells in the early immune response to invading
pathogens. These immune cells are able to recognize a variety of
pathogens through cell surface and intracellular receptors,
including members of the Toll-like receptor (TLR) and Nod-like
receptor (NLR) families (reviewed in: [1]). Engagement of TLRs
results in the activation of MAPK and NF-kB signalling pathways,
leading to expression and release of pro-inflammatory cytokines
and antimicrobial peptides as well as induction of cell death.
Activation of intracellular NLR by a variety of microbial molecules
leads to inflammasome formation, caspase-1 activation and
subsequent formation and release of interleukin-1b (IL-1b),
thereby creating an intracellular surveillance system for pathogens
[2,3].
NALP3 (formerly known as cryopyrin) belongs to the family of
NLR proteins. Upon activation, NALP3 assembles with the
adaptor protein ASC to form a protein-complex termed the
NALP3 inflammasome [4]. CARD-8 (also known as TUCAN) has
been suggested to be a binding partner of NALP3 but its
functional role in inflammasome regulation is not clear. The
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then cleaves and produces the pro-inflammatory cytokines IL-1b
and IL-18 from their inactive pro-forms. b-amyloid, Staphylococcus
aureus, bacterial RNA, and uric acid crystals are some of the stimuli
found to activate the NALP3 inflammasome [5,6,7,8].
In addition to their role in inflammation, NLRs have also been
indicated to link innate immunity to cell death signalling (reviewed
in: [9]). The NLR-linked cell death involves apoptosis and necrosis
but also the two newly recognised cell death programmes,
pyroptosis and pyronecrosis [10,11]. Apoptosis [12] is triggered
by a wide array of intracellular and extracellular signals via two
main routes, the intrinsic pathway and the extrinsic pathway,
respectively (reviewed in: [13]). The intrinsic route is activated
inside the cell and is mediated by mitochondrial damage and
activation of caspase-9. The extrinsic route is initiated by ligation
and activation of extracellular death receptors, leading to caspase-
8 activation. Both caspase-9 and -8 will subsequently activate
downstream caspase-3, leading to apoptosis. The apoptotic process
in neutrophils is controlled by several anti-apoptotic molecules,
including the Bcl-2 family protein Mcl-1 and Akt (also known as
protein kinase B) [14].
During acute inflammation, neutrophil granulocytes are
recruited to the site of infection to phagocytose and clear the
tissue from invading pathogens. Since they are short-lived and
readily go into apoptosis, tissue macrophages are recruited to
ingest the apoptotic neutrophils to prevent tissue damage and
facilitate resolution of inflammation (reviewed in: [15,16,17].
Cryopyrin-associated periodic syndromes (CAPS) are systemic
auto-inflammatory diseases that appear to depend on heterozy-
gous mutations in the gene encoding NALP3, i.e. NLRP3 (Gen
Bank: NG 007509.2) (reviewed in: [18]). CAPS-associated
mutations in the NLRP3 gene are thought to cause constitutive
inflammasome assembly and thereby a constant and uncontrolled
production of IL-1ß [4,19]. Patients suffering from CAPS often
show dramatic improvement upon IL-1b blockade using an IL-1b
receptor antagonist (IL-Ra) [18,20], which indicates an important
role of this cytokine in the pathogenesis of these diseases.
Traditionally, the CAPS include Familial Cold Auto-inflammatory
Syndrome (FCAS, also known as Familial Cold Utricaria), Muckle
Wells Syndrome (MWS) and Neonatal Onset Multisystem
Inflammatory Disease (NOMID). Over-expression of NALP3
and CAPS-associated mutant NLRP3 , respectively, have been
shown to induce cell death in monocytes [21,22,23,24].
We have previously reported on a patient with a long history of
inflammatory disease resulting from excessive IL-1b production,
who was found to be a heterozygous carrier of two common
polymorphisms in genes encoding proteins of the NALP3
inflammasome, i.e. NLRP3 (Q705K) and CARD-8 (C10X) (Gen
Bank: NM 001184900) [25]. The patient’s phenotype was distinct
from those of typical FCAS, MWS or NOMID, thereby adding to
the spectrum of CAPSs.
One distinct feature of this patient was an easily triggered and
prolonged inflammatory response with accumulation of neutro-
phil granulocytes, suggesting that the normal resolution of
inflammation was impaired. We therefore investigated if the
process of apoptosis and elimination of apoptotic cells were
altered in four patients carrying the NLRP3/CARD-8 polymor-
phisms. We could show that neutrophil apoptosis, as detected by
annexin V staining and mitochondrial damage, was significantly
delayed and linked to increased expression and activity of the
anti-apoptotic proteins Akt and Mcl-1. Impaired neutrophil
apoptosis could thus affect the normal resolution and prolong
inflammation in these patients.
Materials and Methods
Reagents and antibodies
The chemicals used were as follows: Benzonase (Merck);
luminol (5-amino-2,3-dihydro-1,4-phtalazinedione), Dimethyl sulf-
oxide (DMSO), fMet-Leu-Phe, phorbol 12-myristate 13-acetate
(PMA), diphenylene iodinium (DPI) and purified lipopolysaccha-
ride (LPS) from Escherichia coli O26:B6 from Sigma Chemical Co;
Annexin V apoptosis kit (R&D Systems); Polymorphprep
TM and
Lymphoprep
TM (Axis shield PoC AS). The reagents used for cell
culture i.e. RPMI-1640, Dulbecco’s Modified Eagle’s Medium
(DMEM), L-glutamine, fetal calf serum, came from Life
Technologies. Recombinant human gamma-Interferon (IFN-c),
AKT inhibitor 10-(49-(N-diethylamino)butyl)-2-chlorophenoxa-
zine (AKT-X), ERK inhibitor PD 98059, and the caspase-1
inhibitor z-YVAD-fmk were from Calbiochem.
The primary antibodies and their sources were as follows:
Rabbit polyclonal antibodies against Mcl-1 (sc-819), and b-actin
(sc-1616) were purchased from Santa Cruz; antibodies directed
towards phosho-Akt (Ser473; 193H12; rabbit mAb), total-Akt
(9272; rabbit polyclonal), and rabbit mAb against phospho-p44/
42 MAPK (Thr202/Tyr204; 197G2) and total-p44/42 MAPK
(Erk1/2; 137F5) from Cell Signalling Technologies. The fluores-
cein isothiocyanate (FITC)-conjugated antibody recognising the
ligand-binding domain of the CD11b-integrin (mouse mAb,
CBRM1/5) was from eBioscience. Antibodies (mAb) directed
against CD11b (P3) or CD18 (P1–2, P4), their isotypic antibodies,
and the FITC-conjugated secondary antibodies were from Dako.
Study subjects
Blood was collected from four patients of Northern European
descent (3 men and 1 woman; mean age: 59.2 (33–66) years old).
The patients were all admitted to the clinic due to inflammatory
related diseases without specified diagnosis. They all displayed
high CRP and WBC with neutrophil granulocytes predominating,
but their symptoms varied and included recurrent fever (P1, 3–4),
arthritis (P1–3) and myalgia (P3–4). (For more detailed Case
reports, see Data S1.) Genetic analysis showed that the patients
carried the NLRP3 (Q705K; rs35829419) and CARD-8 (C10X;
rs2043211) polymorphisms [25], but did not carry any disease-
causing mutations in the NLRP3, MEFV or TRAPS genes. Healthy
volunteers, matched in age and gender of the patients with normal
routine laboratory tests (Table 1) and wild type NLRP3 gene, were
used as controls in a paired patient-control setting for the in vitro
studies (denoted controls). Two controls carried the common
CARD-8 (C10X) polymorphism, which allele frequency is found in
34% of the Swedish population [25]. In addition, coded blood
donor blood from 3 healthy asymptomatic carriers of the NLRP3
(Q705K) and CARD-8 (C10X) polymorphisms and from 6 healthy
non-carriers was collected (denoted carriers and non-carriers,
respectively), as well as blood from randomly chosen healthy blood
donors (denoted donors).
At the time of experiments, P1 and P4 were treated with the IL-
Ra anakinra (Kineret
TM; 100 mg subcutaneously every 24 h), and
due to the ongoing treatment, the patients had no clinical
symptoms at the time of experiment. According to the manufac-
turer, the half-life of this drug is 4–6 h, and administration of
anakinra was therefore withdrawn from the patients for at least
24 h prior to performance of experiments (unless otherwise stated).
P2 started treatment with anakinra after the experiments were
performed and his symptoms improved. P3 was on a steady
maintenance dose of colchicine and low-dose prednisolone, and
her disease has, so far, not required additional therapy.
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Peripheral human blood was drawn from patients and healthy
volunteers and collected in heparin-containing vacutainer tubes,
and neutrophils and monocytes were isolated by means of density
gradient centrifugation, as previously described [26,27]. Briefly,
whole blood was layered over a gradient consisting of Lympho-
prep
TM layered over Polymorphprep
TM, and centrifuged for
40 min at 4806 g at room temperature. The band rich in
polymorphonuclear cells was collected and contaminating erythro-
cytes were removed by hypotonic lysis. The obtained cell
suspension, consisting of .95% neutrophils, was washed twice
and resuspended in RPMI-1640 supplemented with 10% heat
inactivated fetal calf serum and 2 mM L-glutamine (referred to as
RPMI-medium). The cells were kept on ice prior to the
experiments. Macrophages were, similarly isolated using gradient
centrifugations, prepared from peripheral blood monocytes that
hadbeen culturedinDMEMcontaining10%humanserum for6–8
days. The medium was changed every 3 days and was replaced with
DMEM without serum before being used. As indicated in the figure
legends, some experiments did not include all four patients, since in
some matched control individuals the number of isolated neutro-
phils was too few to be able to complete all analyses.
Bacteria
Staphylococcus aureus strain Wood 46 (American Type culture
Collection) was grown statically overnight at 37uC, diluted and
cultured under agitation for an additional 3 h to obtain bacteria in
log phase [28]. The bacteria were washed, resuspended in RPMI-
medium and kept on ice until further handling.
Induction of neutrophil apoptosis
Freshly isolated neutrophils (2610
6) were seeded in a 24-well
tissue culture plate, after which they were pre-warmed for 10–
15 min at 37uC in a humidified CO2 incubator (5% CO2, 95%
air) and subsequently exposed to pre-warmed bacteria (bacter-
ia:cell ratio of 10:1) or medium (spontaneous apoptosis) [27,28].
Infection was stopped after 1 h by adding gentamicin (50 mg/ml),
and the incubation was continued for up to 20 h at 37uCi n5 %
CO2. At indicated time points, the cells were washed with
phosphate buffered saline (PBS) and used for further analysis.
Measurement of apoptosis
As an indicator of early apoptosis, the exposure of phosphati-
dylserine (PS) on the surface of neutrophils was analyzed by using
FITC-conjugated annexin V/propidium iodide (PI)-counter
staining (R&D Systems), as previously described [29]. The
fluorescence (FL-1 versus FL-2) of individual cells was determined
by flow cytometry using a FACSCalibur (Becton Dickinson, San
Jose, CA/USA). At least 10,000 cells were counted in each sample
and analyzed using Cell Quest software. Gating using forward
scatter (FSC) versus side scatter (SSC) was performed to exclude
cell debris. A rise in FITC fluorescence (FITC+/PI-), correspond-
ing to increased exposure of PS, was considered to reveal early
apoptotic neutrophils, whereas elevation of both FITC and PI -
fluorescence was regarded as indicating late apoptotic or necrotic
cells [30].
Mitochondrial membrane potential (DYm)
Mitochondrial membrane potential (DYm) was assessed by use
of tetramethylrhodamine ethyl ester (TMRE), which accumulates
in the mitochondrial matrix. Decreased DYm was indicated by a
reduction in the intensity of TMRE-induced red fluorescence as
detected at the end of experiments by flow cytometric analysis
[27]. Briefly, neutrophils were collected and loaded with RPMI-
medium supplemented with 1 mM TMRE; this was done for
15 min in the dark at 37uC. Thereafter, the cells were analysed by
Table 1. Laboratory characteristics of patients and controls.
P1 (*1977) = P2 (*1952) = P3 (*1970) R P4 (*1944) = C1-4
b p values
c
Q705K/C10X Q705K/C10X Q705K/C10X Q705K/C10X
a
CRP (mg/L)
d 1 2 9 6 72 38 2,1060 0.0187
normal range ,10
ESR (mm/h)
d 80 64 8 56 5.263.2 0.0239
normal range 1–12
WBC (610
9/L)
d 23.3 11.6 12.2 15.7 5.660.8 0.0098
normal range 3.5–8.8
IL-1ß (pg/mL)
Plasma 1.6 1.5 - 1.6 0.460.13 ,0.0001
Supernatant 99 137 69 55 28611 0.0172
LPS+ATP 441 837 431 515 5366142 ns
e
CD18 (MFI) 239 329 210 198 2576123 ns
CD11b high affinity (MFI) 80 116 50 27 84646 ns
ROS (peak value, CPM)
fMet-Leu-Phe (610
7) 35.8 - 7.8 4.7 5.162.5 ns
PMA (610
8) 4.7 - 2.4 4.8 3.361.3 ns
*Year of birth.
aHomozygote carrier of CARD-8 (C10X).
bData are given as mean 6 SD,
cStudent’s t-test was used to compare P1-P4 against their age and gender (=, male; R, female) matched controls (C1–C4).
dMeasured at the accredited Clinical Chemistry Laboratory at Linko ¨ping University Hospital, Sweden.
ens=not statistically significant.
doi:10.1371/journal.pone.0031326.t001
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wavelength of 488 nm, and monitoring the red fluorescence in the
FL-3 channel (650 LP filter). At least 10,000 cells were counted in
each sample and analyzed using Cell Quest software. Gating using
FSC versus SSC was performed to exclude cell debris.
Protein detection by Western Blot
Protein detection by western blotting was performed as
previously described [28]. In brief: neutrophils (2610
6 per sample)
were incubated at 37uC. Cells were withdrawn at different time
points, given ice-cold PBS supplemented with 1 mM Na3VO4 and
1 mM Pefabloc, and then subjected to rapid centrifugation. Each
pellet was dissolved in Laemmli sample buffer and boiled for
10 min. Equal amounts of proteins were separated by 8–16% SDS
polyacrylamide gel electrophoresis (PAGE) and electrotransferred
onto nitrocellulose membranes. The membranes were blocked
with 5% milk powder in PBS Tween-20 (0.075%) and incubated
with primary antibodies recognizing Mcl-1 (1:250), AKT (1:500),
phospho-AKT (1:1000), total-ERK and phospho-ERK (1:1000),
or with b-actin (1:2000) as a loading control. If the molecular
weight of the protein of interest overlapped with the weight of
another protein, the blots were stripped and re-probed; otherwise,
membranes from the same blot were split according to the
molecular standard and then used to detect several proteins. The
specific proteins were detected with a commercial enhanced
luminol-based chemiluminescent (ECL) kit (Amersham). Densito-
metric analysis of bands was performed using Quantity One (Bio
Rad).
Caspase-1 activity and Interleukin-1 b analysis
Caspase-1 activity was measured in monocytes and neutrophils
using a fluorometric caspase-1 assay (R&D systems) [25]. The
fluorescence was recorded at 535 nm after excitation at 450 nm in
a Chameleon multi-label detection platform (Hidex OY).
IL-1b concentrations were assessed in Heparin-plasma or in the
supernatants of stimulated monocytes using a LINCOplex kit
(LINCO Research Inc.) [25]. The samples were examined using
LuminexH 100
TM system. The data was analyzed using the
software program StarStation 2.0 (Applied Cytometry Systems).
Determination of reactive oxygen species
(ROS)-production
A luminol-amplified chemoluminescence assay was used to
determine production of ROS in isolated neutrophils stimulated
with fMet-Leu-Phe (mostly an extracellular production) or PMA
(mostly an intra-cellular production), as previously described [29].
The measurements were performed using a six-channel Biolumat
LB9505 (Berthold Co., Wildbad, Germany).
CD11/CD18-integrin expression and affinity
Integrins expressed on cells in whole blood were immuno-
labelled [31] with fluorescence-conjugated antibodies either
recognizing the CD11b/CD18-integrin or the ligand-binding
domain of the CD11b-integrin (CBRM1/5) [32]. Contaminating
erythrocytes were lysed, the samples were centrifuged, and the
cells fixed in 0.1% paraformaldehyde (PFA). Granulocytes
(predominantly neutrophils) were gated using FSC versus SSC,
and mean fluorescence intensity of 5–10 000 cells/sample was
subsequently analysed by flow cytometry (FACSCalibur). Non-
specific binding was determined using an isotypic antibody, and
autofluorescence was routinely analysed, and found to be
negligible.
Cytokine production by macrophages stimulated with
apoptotic neutrophils
Infected or uninfected neutrophils were washed three times in
PBS containing 50 mg/mL gentamicin to clear extracellular
bacteria, resuspended in DMEM without serum and added to
macrophages (5610
5 neutrophils/well) at 2:1 (neutrophil:macro-
phages) ratio, and the supernatants were collected after 20 h. As a
control, apoptotic neutrophils alone were incubated for 20 h in
DMEM without serum. The supernatants were centrifuged to
remove particular debris and stored in aliquots at -70uC. Cytokine
concentrations in the culture supernatants were detected by
ELISA, using ELISA MAX
TM SET Deluxe kits according to the
instructions provided by the manufacturer Nordic BioSite (Ta ¨by,
Sweden).
To assess the number of ingested apoptotic neutrophils in
macrophages, we performed a phagocytic assay using Molecular
Probes CellTracker
TM Green CMFDA (5-chloromethylfluorescein
diacetate) for labelling of neutrophils prior to exposure to bacteria
or UV irradiation (as control of non-infected apoptotic cells).
Macrophages were allowed to interact with the apoptotic cells no
longer then 2 h since the fluorescence of apoptotic cells co-
incubated and digested by macrophages for 20 h were low in
fluorescence. After 2 h the wells were vigorously washed to remove
non-ingested neutrophils and the macrophages were scraped with
cold Krebs-Ringer glucose (KRG) and analysed by flow cytometry
or fixed in 2% PFA in KRG for 20 min (for macrophages cultured
on glass cover slips), mounted with ProLongH Gold anti-fade
reagent (Molecular Probes) and analysed by microscopy.
Ethical considerations
Genetic analyses, as well as the cell biology analyses were
performed after written informed consent from patients and the
control persons. The study protocol was approved by ethics
committee at Linko ¨ping University, and the study was conducted
in accordance with the ethical guidelines of Declaration of
Helsinki.
Statistical analysis
Statistical analysis was performed using Prism 4 for Macintosh
(version 4.0a) from GraphPad Software (GraphPad, San Diego,
CA). For the age and gender matched data, the paired two-tailed
Student’s t-test was used, unless otherwise indicated. p val-
ues,0.05 were considered statistically significant.
Results
Markers of inflammation
The patients, who were carriers of the combined NLRP3
(Q705K) and CARD-8 (C10X) polymorphisms, displayed in-
creased inflammatory responses, with raised levels of C-reactive
protein (CRP), elevated erythrocyte sedimentation rate (ESR) and
white blood cell (WBC) count (Table 1). Also, the spontaneous
caspase-1 activity (data not shown) as well as IL-1b levels in plasma
and cell supernatants were elevated in these patients compared to
their controls (Table 1).
Spontaneous apoptosis of neutrophils from patients with
polymorphisms in the NALP3 inflammasome
After 6 h of in vitro culture, the patients’ neutrophils displayed
significantly delayed spontaneous apoptosis (mean 6.2%) com-
pared to neutrophils from healthy controls (mean 23.8%;
Figure 1A), as detected by annexin V-stained phosphatidylserine.
During apoptosis, mitochondrial damage is part of the apoptotic
Dysregulated Innate Response by NALP3 Polymorphism
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e31326Figure 1. Spontaneous apoptosis of neutrophils from patients with polymorphisms in the NALP3 inflammasome. Neutrophils, isolated
from whole blood of patients (black symbols/bars) or controls (C; grey symbols/bars), were incubated at 37uC for 6 h (A, B, E)o r2 0h( C,D) after
which the degree of apoptosis was evaluated by flow cytometry by detecting the surface exposure of phosphatidylserine using FITC-conjugated
annexin V (A, C, E) and by assessing the mitochondrial membrane potential (DYm) of the neutrophils by the use of TMRE (B, D). (A–D) Data are
presented as % FITC-Annexin V+ cells or % TMRE-dim cells for each patient (P1¤,P 2 &,P 3 m,P 4N) and its matched control (grey symbols). Black
hyphens indicate mean values. (E) The degree of neutrophil apoptosis was investigated in one patient (P1) at 4, 24 and 34 h post anakinra-
administration, and each bar show mean values from two separate experiment performed at different days for the patient (black bars) and mean
values 6 SD for 6 matched controls (C; grey bar). * and *** represents significant difference: p,0.05 and ,0.001, respectively.
doi:10.1371/journal.pone.0031326.g001
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decreased mitochondrial membrane potential (DYm). By using the
cationic and lipophilic dye TMRE, mitochondrial damage was
evaluated by flow cytometry as percentage of cells with a
decreased DYm. After 6 h of in vitro culture, the patients had
fewer cells with decreased DYm compared to the controls (12.4%
versus 42.1%; Figure 1B).
By 20 h of in vitro culturing, an overall increased spontaneous
apoptosis was evident, but was still delayed in patients (mean
35.5%) compared to the control (mean 50.2%; Figure 1C). Also,
the number of neutrophils with decreased DYm was reduced
among patients compared to controls after 20 h (35.5 vs. 63.7%;
Figure 1D). Taken together, these data showed that neutrophils
from patients with polymorphisms in the NALP3 inflammasome
exhibit delayed apoptosis.
To test whether IL-1b blockade influence the rate of neutrophil
apoptosis, blood from one of the patients (P1) was sampled at
different time-points after administration of the IL-1 receptor
antagonist anakinra. Delayed apoptosis was observed in the
patient’s neutrophils regardless if tested 4 h, 24 h or 34 h after
administration of the drug (Figure 1E). To reduce pain and
suffering for the patients, all subsequent experiments were
therefore performed $24 h after administration of the drug
(unless otherwise stated).
Expression of anti-apoptotic protein Mcl-1 and Akt in
neutrophils
The finding that neutrophils from patients with
NLRP3(Q705K)/CARD-8(C10X) polymorphisms in the NALP3
inflammasome showed delayed apoptosis, prompted us to
investigate how different regulators of apoptosis were involved in
these patients. Neutrophils do not express the anti-apoptotic
protein Bcl-2, but instead the homologue Mcl-1 is considered a
major survival signalling protein. De novo synthesis and turnover of
Mcl-1 is correlated with the reduction in apoptosis [33] and
gradual loss of Mcl-1 during apoptosis releases pro-apoptotic Bcl-2
proteins from their Mcl-1 heterodimerization, which ultimately
leads to mitochondrial membrane permeabilization and apoptosis
[34]. Already directly after isolation, the neutrophil expression of
Mcl-1 was 1.8-fold higher in patients compared to the healthy
controls (p,0.001; Figure 2C and E). The expression of Mcl-1 in
the patients’ neutrophils increased during in vitro culturing,
reaching 2.2-fold difference after 6 h (p,0.01) and declined at
20 h of incubation, but was still significantly higher than the
maximum Mcl-1 expression in the controls’ neutrophils seen at
any time-point (Figure 2C and E).
The PI3K/Akt pathway relays its anti-apoptotic signals via
phosphorylation of Bid and induction of Mcl-1 gene expression
[35]. In the patients’ neutrophils, both total and phosphorylated
Akt were higher at all time-points measured (Figure 2A and B).
Although, the level of phosphorylated Akt peaked at start (0 h) of
in vitro culture for neutrophils from P1 and P3, and at 6 h for P2,
the level of phosphorylation of Akt in the group as such (compiled
data P1–P3; Figure 2A) was substantially higher and more
sustained than in the five tested healthy controls (significant at
6h ,p=0.021). At start of culture, the total Akt expression was
almost similar in neutrophils from both patients and controls
(Figure 2B and E). Whereas the total Akt expression gradually
decreased during culture for control neutrophils, the expression of
Akt in patients’ neutrophils increased with time, and peaked at 6 h
with 2.7-fold more Akt (p=0.0079), and stayed significantly
increased compared to controls also at 20 h (p=0.024). The Mcl-1
and Akt data indicate sustained presence of survival signals in the
neutrophils carrying Q705/C10X inflammasome polymorphisms.
Involvement of the anti-apoptotic protein ERK (p42/44
mitogen-activated protein kinase, p42/44MAPK) was also inves-
tigated (Fig. 2D and E). In neutrophils from both patients and
controls, there was a sustained expression of total ERK protein
during the course of in vitro culture (data not shown). In addition,
there were no significant differences in neither total nor
phosphorylated ERK between neutrophils from patients and
controls.
The effect of Akt and ERK inhibition on delayed
apoptosis
It has previously been shown that inhibition of Akt enhances
apoptosis [36]. To further link together the delayed apoptosis in
the patients with an up-regulated expression and activation of the
anti-apoptotic proteins, we investigated the effect of Akt/ERK
inhibition in regulating apoptosis. Isolated neutrophils were
incubated with the Akt or ERK inhibitors, AKT-X and
PD980559, respectively. Inhibition of Akt, but not of ERK,
significantly enhanced apoptosis in the patents’ neutrophils
(Figure 3A) to an apoptotic level similar to untreated cells from
the control individuals (3967.2 vs. 4262.3% apoptosis), whereas
inhibition of Akt resulted only in minimal effects on spontaneous
induced cell death in the control cells (Figure 3A). The role of Mcl-
1 could not be further investigated, since there are no available
pharmacological inhibitors against Mcl-1.
Inhibition of caspase-1
To analyze whether the enhanced caspase-1 activity is directly
linked to the delayed apoptosis in the patients, we utilized the
caspase-1 inhibitor z-YVAD-fmk. Apoptosis was not restored in
the cells from the patients after exposure to the inhibitor. Instead,
neutrophils obtained from both patients and control subjects
showed slightly decreased apoptosis and mitochondrial damage
(Figure 3B).
Priming and expression of b2-integrins
It has been shown that inflammatory and exudate neutrophils
are primed and show enhanced expression of ß2-integrins [37]
and delayed apoptosis [14]. To evaluate if the neutrophils
obtained from patients were pre-activated, the expression and
affinity of the b2-integrin CD11b/CD18 was analyzed. No
activation of CD11b/CD18 was discernible when detecting the
total amount of CD11b/CD18-integrins, as well as the number of
high affinity CD11b-integrins, suggesting that the observed effects
were not due to priming (Table 1). The expression and affinity of
CD11b/CD18-integrins were similar regardless if measured 4 h,
24 h or 34 h after anakinra administration (data not shown).
Generation of reactive oxygen radicals (ROS)
Since the generation of ROS is suggested to play an important
role in apoptosis of neutrophils and macrophages [38,39,40,41],
we assessed the amounts of ROS after challenging with the
bacterial peptide fMet-Leu-Phe or with the phorbol ester PMA
that induces a receptor-independent response. No significant
differences were detected between the patients’ and controls’
neutrophils neither of fMet-Leu-Phe nor PMA generated ROS
(Table 1).
Spontaneous apoptosis in asymptomatic carriers vs. non-
carriers
Given the fact that the NLRP3 (Q705K)/CARD-8 (C10X)
polymorphisms are common in the Swedish population; we
wanted to elucidate if their presence per se affect apoptosis. Three
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e31326Figure 2. Expression of anti-apoptotic protein Mcl-1, Akt and ERK in neutrophils. Neutrophils, isolated from whole blood of patients (P1–3;
black squares) or controls (grey triangles), were incubated at 37uC for indicated times, before lysed. Samples were analyzed by SDS-PAGE and
immunoblotted with anti-bodies directed against phosphorylated AKT (E: first lane), total AKT (E: second lane), phosphorylated ERK (E: third lane), or
Mcl-1 (E: fifth lane). The blots were stripped and re-probed with b-actin as a control for equal loading (E: fourth and sixth lane). (E) The blots shown
are representative from 3 (patients) or 5 (controls) independent experiments. (A–D) The blots were scanned and the relative intensity of each band
was quantified, and data are normalized to b-actin and presented as mean for two (patients: 1 and 3 h) or mean 6 SEM for three (patients: 0, 6 and
20 h) or five (controls) independent experiments. *, ** and *** represents significant difference: p,0.05, ,0.01 and ,0.001, respectively.
doi:10.1371/journal.pone.0031326.g002
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carriers, collected from healthy blood donors, were examined.
There were no differences in IL-1b levels in plasma between
asymptomatic carriers and non-carriers (0.4160.04 vs.
0.4360.18 pg/mL). In addition, spontaneous apoptosis, analyzed
by both annexin V and DYm, did not significantly differ between
the carriers and non-carriers, neither after 6 h nor 20 h (Figure 4);
suggesting that the polymorphisms per se are not enough for disease
development.
Microbe-induced apoptosis
Next, we investigated the impact of microbes on neutrophil
apoptosis using S. aureus as a microbial stimulus. The level of
microbe-induced apoptosis, analyzed by both annexin V and
DYm, after 6 h was enhanced compared to spontaneous apoptosis
in neutrophils from both patients and control subjects (Figure 5A
and B). Even so, the microbe-induced apoptosis was still delayed in
neutrophils isolated from the patients compared to cells from the
control subjects (Figure 5A and B).
Secretion of TNF in macrophages stimulated with
apoptotic neutrophils
Macrophages play an important role in clearing the tissue from
apoptotic cells and thereby regulate resolution of inflammation.
We have previously shown that when infected apoptotic
neutrophils are cleared by macrophages, a pro-inflammatory
response is elicited with release of pro-inflammatory cytokines, like
TNF and IL-12 [28,42]. In the present patients, the enhanced
accumulation of neutrophils may put a great challenge on the
clearing capacity of tissue macrophages. Impaired capacity to clear
apoptotic cells could thus affect both resolution of inflammation
and tissue damage during infection. First, the pro-inflammatory
triggering capacity by infected and non-infected apoptotic
neutrophils from patients was compared to those from controls.
Neutrophils from patients or controls were treated with S. aureus to
allow phagocytosis and induction of apoptosis [28], and then
exposed to macrophages derived from monocytes isolated from
blood of health blood donors. Following 20 h of co-culture,
macrophage-secreted TNF was measured in the culture superna-
tants. There was no difference between patients’ or controls’
neutrophils in their ability to induce macrophages to produce the
pro-inflammatory cytokine TNF (Figure 6A). However, the
macrophages response was elicited only with bacteria-induced
apoptotic neutrophils.
Second, we investigated if there was a difference in the ability of
patients’ and controls’ macrophages to respond to infected and
non-infected apoptotic neutrophils, in order to discern differences
in activation and clearance. Donor blood-derived neutrophils were
used to stimulate either control or patient derived macrophages.
When evaluating TNF produced (Figure 6B), the patients’
macrophages showed decreased production of TNF in response
to bacteria-induced apoptotic neutrophils. Still, although the
patients’ macrophages showed a 50–65% decreased ability to
produce TNF in response to bacteria-induced apoptotic neutro-
phils compared to control macrophages, there was no difference in
TNF in patients and controls when stimulated with IFNc+ LPS.
To rule out the possibility that the observed effect was due to
reduced capacity of the patient macrophages to phagocytose, we
assessed, by microscopy, the number of apoptotic neutrophils
taken up by the macrophages. Quantification of the number of
apoptotic cells taken up by the macrophages showed that there
was no significant difference in phagocytosis capacity between
patient and control macrophages (data not shown).
Discussion
To regulate the acute inflammatory process, a balance must
exist between accumulation and elimination of exudate inflam-
matory cells, primarily neutrophils. This process is regulated by
spontaneous or microbe-induced apoptosis, together with the
subsequent elimination of apoptotic cells by tissue macrophages
[16,43]. Defects in apoptosis and/or elimination of neutrophils
may lead to profound and devastating inflammatory and
immunological conditions. Since a hallmark of the patients in
the present study is leukocytosis, we raised the question whether
the inflammatory feature was related to delayed apoptosis of
Figure 3. The effect of Akt and Erk inhibition on the delayed
apoptosis of neutrophils. Neutrophils, isolated from whole blood of
(A) 3 patients (P1–2, P4; black bars) or 5 controls (grey bars), or (B) from
whole blood of P1 (black bars) and its matched control (grey bars), were
incubated at 37uC for 6 h with or without inhibitors (AKT-X=Akt
inhibitor, PD98059=ERK inhibitor, z-YVAD-fmk=caspase-1 inhibitor).
The degree of apoptosis was evaluated after 6 h by flow cytometry by
detecting the surface exposure of phosphatidylserine using FITC-
conjugated annexin V (A,B), and by assessing the mitochondrial
membrane potential (DYm) of the neutrophils by the use of TMRE (B).
The data shown represent (A) the mean values from three (black bars)
or five (grey bars) individual experiments 6 SEM expressed as fold of
untreated cells, or (B) the mean of two individual experiments.
Student’s t-test was used to compare each patient’s neutrophils with
vs. without inhibitor (** represents significant difference: p,0.01).
doi:10.1371/journal.pone.0031326.g003
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by tissue macrophages.
For all four patients, who were carriers of the combined
polymorphisms of NLRP3(Q705K)/CARD-8(C10X) and showing
an inflammatory disease phenotype, a delayed spontaneous as well
as microbe-induced apoptosis was clearly observed. It is known
that inflammatory and exudate neutrophils display delayed
apoptosis [44,45]; a mechanism which could explain why the
patients’ cells showed altered apoptosis. However, the delayed
apoptosis was apparent irrespective of clinical symptoms, since
anakinra treatment, which effectively reversed inflammation, did
not affect the apoptotic process. Although there is no correlation to
clinical symptoms, one could anticipate that the patients’
neutrophils where primed due to constitutive IL-1b producing
activity. Nevertheless, the patients’ neutrophils showed no signs of
priming or activation as demonstrated by an equivalent expression
of CD11b/CD18 as compared to controls. These results rule out
an enhanced anti-apoptotic effect caused by CD11b/CD18-
integrins, known to occur during adhesion and transmigration
[46].
One major pathway involved in neutrophil apoptosis is linked to
the production of ROS, generated by the membrane-bound
NADPH-oxidase [38,47,48]. ROS may damage lysosomes,
leading to release of cathepsins, which in turn triggers the release
of cytochrome C from mitochondria ultimately affecting its
membrane potential [27,49,50]. We could not detect any altered
ROS production in the patients’ neutrophils. However, there was
still a difference in mitochondrial damage between patients and
controls, suggesting that the intrinsic pathway was affected in a
ROS-independent way. This interpretation is further strengthened
by the fact that the expression levels of the anti-apoptotic protein
Mcl-1, which normally protects the mitochondria, is increased in
the patients’ neutrophils. Lacking both Bcl-2 and Bcl-X, and
showing only sub-detectable levels of A1, neutrophils rely on Mcl-
1 to regulate apoptosis. Mcl-1 levels are dynamically regulated by
activated transcription and translation, but also by changes in its
Figure 4. Spontaneous apoptosis of neutrophils from patients, asymptomatic carriers and non-carriers. Neutrophils, isolated from
whole blood of patients (P1¤,P 2 &,P 3 m) and asymptomatic carriers of the NLRP3 (Q705K)/CARD-8 (C10X) polymorphisms and of non-carriers, were
incubated at 37uC for 6 h (A,B) and 20 h (C,D). The degree of apoptosis was evaluated (10 000 cells/sample) by flow cytometry by detecting the
surface exposure of phosphatidylserine using FITC-conjugated annexin V (A,C) or by assessing the mitochondrial membrane potential (DYm) of the
neutrophils by the use of TMRE (B,D). Data are expressed as % FITC-AnnexinV positive cells or as % cells with decreased membrane potential. Black
hyphens indicate mean values for n=3 (patients and asymptomatic carriers), or n=6 (non-carriers) run in 3 separate experiments performed in
triplicates. One-way ANOVA test with Bonferoni post test was used to determine significance between the different groups (* represents p,0.05).
doi:10.1371/journal.pone.0031326.g004
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of PI3K/Akt and ERK induce posttranslational modification of
Mcl-1, thereby increasing its stability during GM-CSF signalling of
neutrophil survival [21]. Our observation that both Mcl-1 and Akt
are increased suggests that the key feature during the delayed
apoptosis in the patients’ neutrophils could be impaired Mcl-1
turnover. Whether this is due to increased GM-CSF activity and
an overall decreased neutrophil cell death is, however, not clear.
Inflammatory conditions with increased IL-1b, display in-
creased levels of Mcl-1 and delayed neutrophil apoptosis
[52,53,54]. The constant presence of high levels of IL-1b could
thus be the trigger for elevated Mcl-1 levels and subsequent
delayed apoptosis of the patient’s neutrophils. However, blockade
of IL-1b with anakinra, 4 h, 24 h, or 36 h prior to neutrophil
isolation, did not restore the delayed constitutive apoptosis; data
arguing against IL-1b as the main mediator for the elevated Mcl-1
activity and reduced apoptosis in the patients carrying the NLRP3
(Q705K)/CARD-8 (C10X) polymorphisms.
Based on our previous results from monocytes isolated from one
patient [25], as well as data from the present study, and from
studies with transduced THP-1 cells (manuscript submitted), the
NLRP3 (Q705K) is a gain-of-function polymorphism giving rise to
a constantly active inflammasome with constitutive IL-1b
production; in a similar way as found for CAPS mutations
[4,19]. Blocking caspase-1 did however not restore the delayed
apoptosis in the patients’ neutrophils; data that may question a
connection between the altered apoptosis and SNPs of the
NALP3-inflammasome. Monocytes carrying CAPS-associated
NLRP3 mutations rapidly undergo cell death involving loss of
mitochondrial inner transmembrane potential [23,24]. This cell
death is also found to be independent of caspase-1. Still, the ability
to induce cell death is interconnected to the disease-associated
mutations in NLRP3, as demonstrated by investigating a patient
with NLRP3 mosaicism carrying both mutant and non-mutant
cells [24]. In addition, monocyte cell death in CAPS-patients was
found to be dependent on cathepsin B [24]. Whether the delayed
neutrophil apoptosis found in our patients is regulated by
cathepsin B or not is not elucidated in the present study, but it
has been reported that zVAD-fmk and other caspase inhibitors are
also potent cathepsin B inhibitors [55]. This possibility can
therefore not be ruled out. Taken together, these data show that
the contribution of caspase-1 and IL-1b may be of less importance
in NLRP3-induced cell death.
In agreement with our results, Saito et al. [24] found that the
altered monocyte cell death in CAPS patients was not mediated by
the inflammatory milieu and was independent of IL-1-targeted
therapy. In addition, the cell death was independent of disease
severity, and a small number of monocytes carrying NLRP3
mutations were sufficient to evoke systemic inflammation in CAPS
mosaic patients. In our study, the patients, albeit constituting a
heterogeneous group, were all admitted to the clinic due to
inflammatory related diseases without specified diagnosis. They
were found to be carriers of the NLRP3 (Q705K)/CARD-8 (C10X)
polymorphisms, displaying neutrophils with altered apoptosis that
was apparent irrespective of clinical symptoms. To understand the
impact of a dysfunctional NALP3-inflammasome in disease and to
clarify the mechanism of neutrophil cell death in these patients,
additional experiments are needed. Also, we cannot exclude the
possibility that there are other types of genetic abnormalities that
may influence the inflammatory disorders of these patients.
Q705K in combination with C10X has been implicated in
diseases like Crohn’s disease, rheumatoid arthritis and aortic
aneurisms [56,57,58,59]. The fact that NLRP3 (Q705K)/CARD-8
(C10X) polymorphisms are quite prevalent in the healthy
population, taken together with the heterogeneity of these diseases,
as well as of the symptoms of the patients of this study, suggests
these polymorphisms to act as susceptibility factors that in
conjunction with an environmental cue, such as an infection or
by additional genetic variations, predispose for enhanced inflam-
mation. This hypothesis is supported by the present study showing
similar inflammasome status, measured as degree of apoptotic
neutrophils and production of IL-1b, between asymptomatic
carriers and non-carriers. Also, data from transduced THP-1 cells
indicate Q705K/C10X as gain-of-function polymorphisms of low-
Figure 5. Microbe-induced apoptosis of neutrophils from patients with polymorphisms in the NALP3 inflammasome. Neutrophils,
isolated from whole blood of 3 patients (P1–3; black bars) or 3 controls (grey bars), were incubated with S. aureus (bacteria:cell ratio of 10:1) at 37uC.
After 6 h, the degree of apoptosis was evaluated by flow cytometry (A) by detecting the surface exposure of phosphatidylserine using FITC-
conjugated annexin V, and (B) by assessing the mitochondrial membrane potential (DYm) of the neutrophils by the use of TMRE. Data shown are %
FITC-Annexin V+ cells and % TMRE-dim cells, respectively, presented as mean values from three individual experiments 6 SEM. * and ** represents
significant difference: p,0.05 and ,0.01, respectively.
doi:10.1371/journal.pone.0031326.g005
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participate in an inflammatory phenotype depending on other
host related genetic and/or environmental factors. Environmental
factors are suggested to influence disease severity for polymor-
phism involved in familial Mediterranean fever [60,61].
The NALP3 inflammasome is believed to function as an
intracellular pattern-recognition receptor for gram-positive (G
+)
bacteria like Staphylococcus aureus [6]. In ex vivo studies of healthy
individuals, we have previously found a 3-fold increase in IL-1b
upon challenge with S. aureus [25]. In a patient with the NLRP3
(Q705K)/CARD-8 (C10X) polymorphisms, IL-1b was found to
increase 28 times after incubation with this microbe [25]. In the
present study, both patients and control subjects showed an
augmented microbe-induced apoptosis as compared to spontane-
ous apoptosis. Several microbial components (e.g. LPS, peptido-
glycan and CpG DNA) may all rescue neutrophils from apoptosis
[15]. Even so, the S. aureus-induced apoptosis in neutrophils
isolated from the patients was significantly delayed compared to
cells from the control subjects. The finding that microbe-induced
apoptosis is significantly impaired in the patients, indicate that the
increased activity of Mcl-1 and Akt not only affected the
spontaneous apoptosis, but also protects the cell from a strong
exogenous apoptotic stimulus.
A main feature of tissue macrophages during resolution of
inflammation is to phagocytose apoptotic neutrophils, not only
after constitutive apoptosis but also apoptosis that follows ingestion
and killing of invading pathogens. We have earlier shown that
pathogen-induced apoptotic neutrophils trigger a pro-inflamma-
tory response in macrophages [28,42], suggesting that apoptotic
neutrophils can enhance the early innate and the adaptive host
response to certain pathogens. Lack of macrophage response to
apoptotic cells could lead to sustained inflammation and impaired
clearance of microbes. The fact that macrophages from patients
with the NLRP3 (Q705K)/CARD-8 (C10X) polymorphisms
responded weakly to pathogen-induced apoptotic neutrophils
show that the link between the early innate and the adaptive
immune response is impaired in these patients. If this has any
impact on their susceptibility to specific pathogens remains to be
investigated.
To conclude, we have shown that not only the macrophage
response is altered in patients with the combined polymorphisms
of the NALP3 inflammasome, but also the constitutive and
pathogen-induced apoptosis of neutrophils. Whether this is due to
the effect(s) of extracellular anti-apoptotic factors in plasma or
altered intrinsic regulatory mechanisms, is still unclear. The
impaired turnover and clearance of apoptotic neutrophils could
however be one phenotypic characteristic affecting the clinical
feature of these patients both during immunological homeostasis
and when encountering different exogenous stimuli.
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